002370 亚太药业
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资0--00033,454
投资性房地产628-2.79%64612,33300
固定资产350,846-3.81%364,755384,499430,506443,309
在建工程7992,250.00%34090144,437
无形资产56,344-4.83%59,20657,22251,57249,949
商誉0--0000
其他非流动资产48,283-2.56%49,55364,977131,952110,333
456,900-3.65%474,193519,030614,933681,483

流动资产
货币资金686,353-4.74%720,475757,617821,113902,935
应收账款74,657-6.10%79,51089,05969,964117,642
存货81,523-8.89%89,47595,20560,89964,877
其他流动资产69,3105.46%65,72162,96543,872189,384
911,843-4.54%955,1801,004,845995,8491,274,838

流动负债
短期借款0-100.00%50,06050,06100
应付票据0-100.00%2,32030,37000
应付帐款44,182-10.70%49,47759,46153,92644,955
其他流动负债691,3761,053.31%59,94782,491160,224246,564
735,558354.60%161,803222,383214,150291,519
流动资产净值176,285-77.78%793,377782,462781,699983,319
资产总额减流动负债633,185-50.05%1,267,5711,301,4921,396,6311,664,802

非流动负债
长期借款0--000110,160
应付债券0-100.00%639,477900,015861,581820,279
其他非流动负债46,200-2.16%47,220100,211102,08973,954
46,200-93.27%686,6961,000,226963,6701,004,393

总权益
    实收股本609,1800.00%609,171536,687536,618536,558
    储备项目(22,195)-21.56%(28,297)(235,420)(103,657)123,851
股东权益586,9851.05%580,874301,267432,962660,409
非控股权益0--0000